When you google clinical trials today it brings up images of clinical settings, white coats and test tubes. But the first clinical trial was a very different experience.
The House of Lords Committee on Science and Technology yesterday offered a stark warning that the UK risks missing out on the potential health and economic benefits that regenerative medicines have to offer. Its report should not be taken lightly.
On World Cancer Day, it seems like a good time to pause and reflect on the years gone past, and how innovations and research in cancer have affected cancer care.
Writing in a letter to The Times, ABPI Chief Executive Stephen Whitehead and 15 other healthcare representatives have highlighted the work of the healthcare professions and life sciences industry in the campaign for clinical trial transparency.
In its Plan for Growth Review, the Government pledged to speed-up the regulatory process around clinical trials in the UK. This was welcomed by the Association of the British Pharmaceutical Industry and its members who have long called for action.
The ABPI has published a report of its second workshop on clinical trial transparency. The workshop explored the technical standards for data sharing for current, future and past clinical trials and was a follow up to an event held in March 2013.
I was saddened today to read a report in The Independent that accused our industry of exploiting 'loose regulations' for clinical trials in India. This is fundamentally untrue.
Patients in the UK are set to miss out on ground breaking and potentially life-saving clinical trials in the event of the UK leaving the EU. This is especially significant for millions of people living with a form of rare disease, where clinical trials can be their only lifeline to treatment.
Dr Paul Brooker is Chair of the ABPI Nonclinical and Biological Discovery Expert Network (NaBDEN) and is President Europe, Middle East & Asia Pacific (EMEA) and President CRS at Envigo.
It was good to have the opportunity to discuss open access to clinical trial data and the launch of alltrials.net with Sir Iain Chalmers on this morning’s Today Programme.